US FDA Gets Less FY2022 Funding From Senate Than House, Different Inspection Priorities
CDER would receive $17m less in Senate appropriations bill compared to House veion, while CFSAN's total would be nearly $10m less. Overall, Senate bill includes around $50.4m less in funding for FDA than House bill.
You may also be interested in...
The House Appropriations Committee also does not want the agency to become too dependent on alternative inspection tools.
Foreign facility visits may take longer to reach usual levels because of the ongoing coronavirus outbreaks in other countries.
Additional hiring in FDA’s FY 2022 budget request also is expected to help address the inspections delayed by the coronavirus pandemic.